Radiopharmaceuticals Market
Radiopharmaceuticals Market - Global Industry Assessment & Forecast
#
Pages:
148
Base Year:
2022
May - 2023
Format:
Report Code:
VMR-2143
Segments Covered
By
Type Diagnostic Nuclear Medicine, SPECT Radiopharmaceuticals, Technetium-99m, Thallium-201, Gallium-67, Iodine-123, Other, PET Radiopharmaceuticals, F-18, RU-82, Others, Therapeutic Nuclear Medicine, Alpha Emitters, Ra-223, Brachytherapy Isotopes, Intoiodine-125, Palladium-103, Cesium-131, Iridium-192, Other brachytherapy isotopes, Beta Emitters, Intoiodine-131, Yttrium-90, Samarium-153, Lutetium-177, Rhenium-186, Other beta emitters
-
By
Application Diagnostic Applications, SPECT Applications, Cardiology, Bone Scans, Thyroid Applications, Pulmonary Scans, Other SPECT Applications, PET applications, Oncology, Cardiology, Neurology, Other PET applications, Therapeutic Applications, Thyroid Indications, Bone Metastasis, Lymphoma, Endocrine Tumors, Other Indications
-
By
Procedural Volume Assessment Diagnostic Procedures, Therapeutic Procedures, Source
-
By
Source Nuclear Reactors, Cyclotrons
-
By
End User Hospitals, Ambulatory Surgical Centers, Diagnostic Centers, Cancer Research Institutes, Others
-
By
Region North America, Europe, Asia Pacific, Latin America, Middle East & Africa
Snapshot
 Base Year:
|
2022 |
| Forecast
Years:
|
2023 - 2030 |
 Historical
Years:
|
2017 - 2021 |
 Revenue
2022: |
USD 5.2 Billion |
 Revenue 2030:
|
USD 9.75 Billion |
 Revenue CAGR
(2023 - 2030): |
9.4% |
Fastest Growing Region (2023 -
2030)
|
Asia Pacific |
Largest Region (2022):
|
North America |
Customization Offered
Cross-segment Market Size and
Analysis
for Mentioned Segments- Additional Company Profiles (Upto 5
With
No Cost)
- Additional Countries (Apart From
Mentioned Countries)
- Country/Region-specific Report
- Go To Market Strategy
- Region Specific Market Dynamics
- Region Level Market Share
- Import Export Analysis
- Production Analysis
- Others Request
Customization Speak To
Analyst
Radiopharmaceuticals Market Segment Analysis
- Radiopharmaceuticals Type Outlook (Revenue, USD Million, 2018 - 2030)
- Diagnostic Nuclear Medicine
- SPECT Radiopharmaceuticals
- Technetium-99m
- Thallium-201
- Gallium-67
- Iodine-123
- Other
- PET Radiopharmaceuticals
- F-18
- RU-82
- Others
- Therapeutic Nuclear Medicine
- Alpha Emitters
- Ra-223
- Brachytherapy Isotopes
- Intoiodine-125
- Palladium-103
- Cesium-131
- Iridium-192
- Other brachytherapy isotopes
- Beta Emitters
- Intoiodine-131
- Yttrium-90
- Samarium-153
- Lutetium-177
- Rhenium-186
- Other beta emitters
- Radiopharmaceuticals Application Outlook (Revenue, USD Million, 2018 - 2030)
- Diagnostic Applications
- SPECT Applications
- Cardiology
- Bone Scans
- Thyroid Applications
- Pulmonary Scans
- Other SPECT Applications
- PET applications
- Oncology
- Cardiology
- Neurology
- Other PET applications
- Therapeutic Applications
- Thyroid Indications
- Bone Metastasis
- Lymphoma
- Endocrine Tumors
- Other Indications
- Radiopharmaceuticals Procedural Volume Assessment Outlook (Revenue, USD Million, 2018 - 2030)
- Diagnostic Procedures
- Therapeutic Procedures
- Source
- Radiopharmaceuticals Source Outlook (Revenue, USD Million, 2018 - 2030)
- Nuclear Reactors
- Cyclotrons
- Radiopharmaceuticals End User Outlook (Revenue, USD Million, 2018 - 2030)
- Hospitals
- Ambulatory Surgical Centers
- Diagnostic Centers
- Cancer Research Institutes
- Others
-
Regional Outlook (Revenue, USD Billion/Million, 2018 - 2030)
- North America
-
North America Radiopharmaceuticals Market, by Type
- Diagnostic Nuclear Medicine
- SPECT Radiopharmaceuticals
- Technetium-99m
- Thallium-201
- Gallium-67
- Iodine-123
- Other
- PET Radiopharmaceuticals
- F-18
- RU-82
- Others
- Therapeutic Nuclear Medicine
- Alpha Emitters
- Ra-223
- Brachytherapy Isotopes
- Intoiodine-125
- Palladium-103
- Cesium-131
- Iridium-192
- Other brachytherapy isotopes
- Beta Emitters
- Intoiodine-131
- Yttrium-90
- Samarium-153
- Lutetium-177
- Rhenium-186
- Other beta emitters
-
North America Radiopharmaceuticals Market, by Application
- Diagnostic Applications
- SPECT Applications
- Cardiology
- Bone Scans
- Thyroid Applications
- Pulmonary Scans
- Other SPECT Applications
- PET applications
- Oncology
- Cardiology
- Neurology
- Other PET applications
- Therapeutic Applications
- Thyroid Indications
- Bone Metastasis
- Lymphoma
- Endocrine Tumors
- Other Indications
-
North America Radiopharmaceuticals Market, by Procedural Volume Assessment
- Diagnostic Procedures
- Therapeutic Procedures
- Source
-
North America Radiopharmaceuticals Market, by Source
- Nuclear Reactors
- Cyclotrons
-
North America Radiopharmaceuticals Market, by End User
- Hospitals
- Ambulatory Surgical Centers
- Diagnostic Centers
- Cancer Research Institutes
- Others
- U.S.
- U.S. Radiopharmaceuticals Market, by Type
- Diagnostic Nuclear Medicine
- SPECT Radiopharmaceuticals
- Technetium-99m
- Thallium-201
- Gallium-67
- Iodine-123
- Other
- PET Radiopharmaceuticals
- F-18
- RU-82
- Others
- Therapeutic Nuclear Medicine
- Alpha Emitters
- Ra-223
- Brachytherapy Isotopes
- Intoiodine-125
- Palladium-103
- Cesium-131
- Iridium-192
- Other brachytherapy isotopes
- Beta Emitters
- Intoiodine-131
- Yttrium-90
- Samarium-153
- Lutetium-177
- Rhenium-186
- Other beta emitters
- U.S. Radiopharmaceuticals Market, by Application
- Diagnostic Applications
- SPECT Applications
- Cardiology
- Bone Scans
- Thyroid Applications
- Pulmonary Scans
- Other SPECT Applications
- PET applications
- Oncology
- Cardiology
- Neurology
- Other PET applications
- Therapeutic Applications
- Thyroid Indications
- Bone Metastasis
- Lymphoma
- Endocrine Tumors
- Other Indications
- U.S. Radiopharmaceuticals Market, by Procedural Volume Assessment
- Diagnostic Procedures
- Therapeutic Procedures
- Source
- U.S. Radiopharmaceuticals Market, by Source
- Nuclear Reactors
- Cyclotrons
- U.S. Radiopharmaceuticals Market, by End User
- Hospitals
- Ambulatory Surgical Centers
- Diagnostic Centers
- Cancer Research Institutes
- Others
- U.S. Radiopharmaceuticals Market, by Type
- Canada
- Canada Radiopharmaceuticals Market, by Type
- Diagnostic Nuclear Medicine
- SPECT Radiopharmaceuticals
- Technetium-99m
- Thallium-201
- Gallium-67
- Iodine-123
- Other
- PET Radiopharmaceuticals
- F-18
- RU-82
- Others
- Therapeutic Nuclear Medicine
- Alpha Emitters
- Ra-223
- Brachytherapy Isotopes
- Intoiodine-125
- Palladium-103
- Cesium-131
- Iridium-192
- Other brachytherapy isotopes
- Beta Emitters
- Intoiodine-131
- Yttrium-90
- Samarium-153
- Lutetium-177
- Rhenium-186
- Other beta emitters
- Canada Radiopharmaceuticals Market, by Application
- Diagnostic Applications
- SPECT Applications
- Cardiology
- Bone Scans
- Thyroid Applications
- Pulmonary Scans
- Other SPECT Applications
- PET applications
- Oncology
- Cardiology
- Neurology
- Other PET applications
- Therapeutic Applications
- Thyroid Indications
- Bone Metastasis
- Lymphoma
- Endocrine Tumors
- Other Indications
- Canada Radiopharmaceuticals Market, by Procedural Volume Assessment
- Diagnostic Procedures
- Therapeutic Procedures
- Source
- Canada Radiopharmaceuticals Market, by Source
- Nuclear Reactors
- Cyclotrons
- Canada Radiopharmaceuticals Market, by End User
- Hospitals
- Ambulatory Surgical Centers
- Diagnostic Centers
- Cancer Research Institutes
- Others
- Canada Radiopharmaceuticals Market, by Type
-
Mexico
- Mexico Radiopharmaceuticals Market, by Type
- Diagnostic Nuclear Medicine
- SPECT Radiopharmaceuticals
- Technetium-99m
- Thallium-201
- Gallium-67
- Iodine-123
- Other
- PET Radiopharmaceuticals
- F-18
- RU-82
- Others
- Therapeutic Nuclear Medicine
- Alpha Emitters
- Ra-223
- Brachytherapy Isotopes
- Intoiodine-125
- Palladium-103
- Cesium-131
- Iridium-192
- Other brachytherapy isotopes
- Beta Emitters
- Intoiodine-131
- Yttrium-90
- Samarium-153
- Lutetium-177
- Rhenium-186
- Other beta emitters
- Mexico Radiopharmaceuticals Market, by Application
- Diagnostic Applications
- SPECT Applications
- Cardiology
- Bone Scans
- Thyroid Applications
- Pulmonary Scans
- Other SPECT Applications
- PET applications
- Oncology
- Cardiology
- Neurology
- Other PET applications
- Therapeutic Applications
- Thyroid Indications
- Bone Metastasis
- Lymphoma
- Endocrine Tumors
- Other Indications
- Mexico Radiopharmaceuticals Market, by Procedural Volume Assessment
- Diagnostic Procedures
- Therapeutic Procedures
- Source
- Mexico Radiopharmaceuticals Market, by Source
- Nuclear Reactors
- Cyclotrons
- Mexico Radiopharmaceuticals Market, by End User
- Hospitals
- Ambulatory Surgical Centers
- Diagnostic Centers
- Cancer Research Institutes
- Others
- Mexico Radiopharmaceuticals Market, by Type
-
North America Radiopharmaceuticals Market, by Type
- Europe
-
Europe Radiopharmaceuticals Market, by Type
- Diagnostic Nuclear Medicine
- SPECT Radiopharmaceuticals
- Technetium-99m
- Thallium-201
- Gallium-67
- Iodine-123
- Other
- PET Radiopharmaceuticals
- F-18
- RU-82
- Others
- Therapeutic Nuclear Medicine
- Alpha Emitters
- Ra-223
- Brachytherapy Isotopes
- Intoiodine-125
- Palladium-103
- Cesium-131
- Iridium-192
- Other brachytherapy isotopes
- Beta Emitters
- Intoiodine-131
- Yttrium-90
- Samarium-153
- Lutetium-177
- Rhenium-186
- Other beta emitters
-
Europe Radiopharmaceuticals Market, by Application
- Diagnostic Applications
- SPECT Applications
- Cardiology
- Bone Scans
- Thyroid Applications
- Pulmonary Scans
- Other SPECT Applications
- PET applications
- Oncology
- Cardiology
- Neurology
- Other PET applications
- Therapeutic Applications
- Thyroid Indications
- Bone Metastasis
- Lymphoma
- Endocrine Tumors
- Other Indications
-
Europe Radiopharmaceuticals Market, by Procedural Volume Assessment
- Diagnostic Procedures
- Therapeutic Procedures
- Source
-
Europe Radiopharmaceuticals Market, by Source
- Nuclear Reactors
- Cyclotrons
-
Europe Radiopharmaceuticals Market, by End User
- Hospitals
- Ambulatory Surgical Centers
- Diagnostic Centers
- Cancer Research Institutes
- Others
- U. K.
- U.K. Radiopharmaceuticals Market, by Type
- Diagnostic Nuclear Medicine
- SPECT Radiopharmaceuticals
- Technetium-99m
- Thallium-201
- Gallium-67
- Iodine-123
- Other
- PET Radiopharmaceuticals
- F-18
- RU-82
- Others
- Therapeutic Nuclear Medicine
- Alpha Emitters
- Ra-223
- Brachytherapy Isotopes
- Intoiodine-125
- Palladium-103
- Cesium-131
- Iridium-192
- Other brachytherapy isotopes
- Beta Emitters
- Intoiodine-131
- Yttrium-90
- Samarium-153
- Lutetium-177
- Rhenium-186
- Other beta emitters
- U.K. Radiopharmaceuticals Market, by Application
- Diagnostic Applications
- SPECT Applications
- Cardiology
- Bone Scans
- Thyroid Applications
- Pulmonary Scans
- Other SPECT Applications
- PET applications
- Oncology
- Cardiology
- Neurology
- Other PET applications
- Therapeutic Applications
- Thyroid Indications
- Bone Metastasis
- Lymphoma
- Endocrine Tumors
- Other Indications
- U.K. Radiopharmaceuticals Market, by Procedural Volume Assessment
- Diagnostic Procedures
- Therapeutic Procedures
- Source
- U.K. Radiopharmaceuticals Market, by Source
- Nuclear Reactors
- Cyclotrons
- U.K. Radiopharmaceuticals Market, by End User
- Hospitals
- Ambulatory Surgical Centers
- Diagnostic Centers
- Cancer Research Institutes
- Others
- U.K. Radiopharmaceuticals Market, by Type
- France
- France Radiopharmaceuticals Market, by Type
- Diagnostic Nuclear Medicine
- SPECT Radiopharmaceuticals
- Technetium-99m
- Thallium-201
- Gallium-67
- Iodine-123
- Other
- PET Radiopharmaceuticals
- F-18
- RU-82
- Others
- Therapeutic Nuclear Medicine
- Alpha Emitters
- Ra-223
- Brachytherapy Isotopes
- Intoiodine-125
- Palladium-103
- Cesium-131
- Iridium-192
- Other brachytherapy isotopes
- Beta Emitters
- Intoiodine-131
- Yttrium-90
- Samarium-153
- Lutetium-177
- Rhenium-186
- Other beta emitters
- France Radiopharmaceuticals Market, by Application
- Diagnostic Applications
- SPECT Applications
- Cardiology
- Bone Scans
- Thyroid Applications
- Pulmonary Scans
- Other SPECT Applications
- PET applications
- Oncology
- Cardiology
- Neurology
- Other PET applications
- Therapeutic Applications
- Thyroid Indications
- Bone Metastasis
- Lymphoma
- Endocrine Tumors
- Other Indications
- France Radiopharmaceuticals Market, by Procedural Volume Assessment
- Diagnostic Procedures
- Therapeutic Procedures
- Source
- France Radiopharmaceuticals Market, by Source
- Nuclear Reactors
- Cyclotrons
- France Radiopharmaceuticals Market, by End User
- Hospitals
- Ambulatory Surgical Centers
- Diagnostic Centers
- Cancer Research Institutes
- Others
- France Radiopharmaceuticals Market, by Type
-
Germany
- Germany Radiopharmaceuticals Market, by Type
- Diagnostic Nuclear Medicine
- SPECT Radiopharmaceuticals
- Technetium-99m
- Thallium-201
- Gallium-67
- Iodine-123
- Other
- PET Radiopharmaceuticals
- F-18
- RU-82
- Others
- Therapeutic Nuclear Medicine
- Alpha Emitters
- Ra-223
- Brachytherapy Isotopes
- Intoiodine-125
- Palladium-103
- Cesium-131
- Iridium-192
- Other brachytherapy isotopes
- Beta Emitters
- Intoiodine-131
- Yttrium-90
- Samarium-153
- Lutetium-177
- Rhenium-186
- Other beta emitters
- Germany Radiopharmaceuticals Market, by Application
- Diagnostic Applications
- SPECT Applications
- Cardiology
- Bone Scans
- Thyroid Applications
- Pulmonary Scans
- Other SPECT Applications
- PET applications
- Oncology
- Cardiology
- Neurology
- Other PET applications
- Therapeutic Applications
- Thyroid Indications
- Bone Metastasis
- Lymphoma
- Endocrine Tumors
- Other Indications
- Germany Radiopharmaceuticals Market, by Procedural Volume Assessment
- Diagnostic Procedures
- Therapeutic Procedures
- Source
- Germany Radiopharmaceuticals Market, by Source
- Nuclear Reactors
- Cyclotrons
- Germany Radiopharmaceuticals Market, by End User
- Hospitals
- Ambulatory Surgical Centers
- Diagnostic Centers
- Cancer Research Institutes
- Others
- Germany Radiopharmaceuticals Market, by Type
-
Italy
- Italy Radiopharmaceuticals Market, by Type
- Diagnostic Nuclear Medicine
- SPECT Radiopharmaceuticals
- Technetium-99m
- Thallium-201
- Gallium-67
- Iodine-123
- Other
- PET Radiopharmaceuticals
- F-18
- RU-82
- Others
- Therapeutic Nuclear Medicine
- Alpha Emitters
- Ra-223
- Brachytherapy Isotopes
- Intoiodine-125
- Palladium-103
- Cesium-131
- Iridium-192
- Other brachytherapy isotopes
- Beta Emitters
- Intoiodine-131
- Yttrium-90
- Samarium-153
- Lutetium-177
- Rhenium-186
- Other beta emitters
- Italy Radiopharmaceuticals Market, by Application
- Diagnostic Applications
- SPECT Applications
- Cardiology
- Bone Scans
- Thyroid Applications
- Pulmonary Scans
- Other SPECT Applications
- PET applications
- Oncology
- Cardiology
- Neurology
- Other PET applications
- Therapeutic Applications
- Thyroid Indications
- Bone Metastasis
- Lymphoma
- Endocrine Tumors
- Other Indications
- Italy Radiopharmaceuticals Market, by Procedural Volume Assessment
- Diagnostic Procedures
- Therapeutic Procedures
- Source
- Italy Radiopharmaceuticals Market, by Source
- Nuclear Reactors
- Cyclotrons
- Italy Radiopharmaceuticals Market, by End User
- Hospitals
- Ambulatory Surgical Centers
- Diagnostic Centers
- Cancer Research Institutes
- Others
- Italy Radiopharmaceuticals Market, by Type
-
Spain
- Spain Radiopharmaceuticals Market, by Type
- Diagnostic Nuclear Medicine
- SPECT Radiopharmaceuticals
- Technetium-99m
- Thallium-201
- Gallium-67
- Iodine-123
- Other
- PET Radiopharmaceuticals
- F-18
- RU-82
- Others
- Therapeutic Nuclear Medicine
- Alpha Emitters
- Ra-223
- Brachytherapy Isotopes
- Intoiodine-125
- Palladium-103
- Cesium-131
- Iridium-192
- Other brachytherapy isotopes
- Beta Emitters
- Intoiodine-131
- Yttrium-90
- Samarium-153
- Lutetium-177
- Rhenium-186
- Other beta emitters
- Spain Radiopharmaceuticals Market, by Application
- Diagnostic Applications
- SPECT Applications
- Cardiology
- Bone Scans
- Thyroid Applications
- Pulmonary Scans
- Other SPECT Applications
- PET applications
- Oncology
- Cardiology
- Neurology
- Other PET applications
- Therapeutic Applications
- Thyroid Indications
- Bone Metastasis
- Lymphoma
- Endocrine Tumors
- Other Indications
- Spain Radiopharmaceuticals Market, by Procedural Volume Assessment
- Diagnostic Procedures
- Therapeutic Procedures
- Source
- Spain Radiopharmaceuticals Market, by Source
- Nuclear Reactors
- Cyclotrons
- Spain Radiopharmaceuticals Market, by End User
- Hospitals
- Ambulatory Surgical Centers
- Diagnostic Centers
- Cancer Research Institutes
- Others
- Spain Radiopharmaceuticals Market, by Type
-
Rest of Europe
- Rest of Europe Radiopharmaceuticals Market, by Type
- Diagnostic Nuclear Medicine
- SPECT Radiopharmaceuticals
- Technetium-99m
- Thallium-201
- Gallium-67
- Iodine-123
- Other
- PET Radiopharmaceuticals
- F-18
- RU-82
- Others
- Therapeutic Nuclear Medicine
- Alpha Emitters
- Ra-223
- Brachytherapy Isotopes
- Intoiodine-125
- Palladium-103
- Cesium-131
- Iridium-192
- Other brachytherapy isotopes
- Beta Emitters
- Intoiodine-131
- Yttrium-90
- Samarium-153
- Lutetium-177
- Rhenium-186
- Other beta emitters
- Rest of Europe Radiopharmaceuticals Market, by Application
- Diagnostic Applications
- SPECT Applications
- Cardiology
- Bone Scans
- Thyroid Applications
- Pulmonary Scans
- Other SPECT Applications
- PET applications
- Oncology
- Cardiology
- Neurology
- Other PET applications
- Therapeutic Applications
- Thyroid Indications
- Bone Metastasis
- Lymphoma
- Endocrine Tumors
- Other Indications
- Rest of Europe Radiopharmaceuticals Market, by Procedural Volume Assessment
- Diagnostic Procedures
- Therapeutic Procedures
- Source
- Rest of Europe Radiopharmaceuticals Market, by Source
- Nuclear Reactors
- Cyclotrons
- Rest of Europe Radiopharmaceuticals Market, by End User
- Hospitals
- Ambulatory Surgical Centers
- Diagnostic Centers
- Cancer Research Institutes
- Others
- Rest of Europe Radiopharmaceuticals Market, by Type
-
Europe Radiopharmaceuticals Market, by Type
- Asia Pacific
-
Asia Pacific Radiopharmaceuticals Market, by Type
- Diagnostic Nuclear Medicine
- SPECT Radiopharmaceuticals
- Technetium-99m
- Thallium-201
- Gallium-67
- Iodine-123
- Other
- PET Radiopharmaceuticals
- F-18
- RU-82
- Others
- Therapeutic Nuclear Medicine
- Alpha Emitters
- Ra-223
- Brachytherapy Isotopes
- Intoiodine-125
- Palladium-103
- Cesium-131
- Iridium-192
- Other brachytherapy isotopes
- Beta Emitters
- Intoiodine-131
- Yttrium-90
- Samarium-153
- Lutetium-177
- Rhenium-186
- Other beta emitters
-
Asia Pacific Radiopharmaceuticals Market, by Application
- Diagnostic Applications
- SPECT Applications
- Cardiology
- Bone Scans
- Thyroid Applications
- Pulmonary Scans
- Other SPECT Applications
- PET applications
- Oncology
- Cardiology
- Neurology
- Other PET applications
- Therapeutic Applications
- Thyroid Indications
- Bone Metastasis
- Lymphoma
- Endocrine Tumors
- Other Indications
-
Asia Pacific Radiopharmaceuticals Market, by Procedural Volume Assessment
- Diagnostic Procedures
- Therapeutic Procedures
- Source
-
Asia Pacific Radiopharmaceuticals Market, by Source
- Nuclear Reactors
- Cyclotrons
-
Asia Pacific Radiopharmaceuticals Market, by End User
- Hospitals
- Ambulatory Surgical Centers
- Diagnostic Centers
- Cancer Research Institutes
- Others
- China
- China Radiopharmaceuticals Market, by Type
- Diagnostic Nuclear Medicine
- SPECT Radiopharmaceuticals
- Technetium-99m
- Thallium-201
- Gallium-67
- Iodine-123
- Other
- PET Radiopharmaceuticals
- F-18
- RU-82
- Others
- Therapeutic Nuclear Medicine
- Alpha Emitters
- Ra-223
- Brachytherapy Isotopes
- Intoiodine-125
- Palladium-103
- Cesium-131
- Iridium-192
- Other brachytherapy isotopes
- Beta Emitters
- Intoiodine-131
- Yttrium-90
- Samarium-153
- Lutetium-177
- Rhenium-186
- Other beta emitters
- China Radiopharmaceuticals Market, by Application
- Diagnostic Applications
- SPECT Applications
- Cardiology
- Bone Scans
- Thyroid Applications
- Pulmonary Scans
- Other SPECT Applications
- PET applications
- Oncology
- Cardiology
- Neurology
- Other PET applications
- Therapeutic Applications
- Thyroid Indications
- Bone Metastasis
- Lymphoma
- Endocrine Tumors
- Other Indications
- China Radiopharmaceuticals Market, by Procedural Volume Assessment
- Diagnostic Procedures
- Therapeutic Procedures
- Source
- China Radiopharmaceuticals Market, by Source
- Nuclear Reactors
- Cyclotrons
- China Radiopharmaceuticals Market, by End User
- Hospitals
- Ambulatory Surgical Centers
- Diagnostic Centers
- Cancer Research Institutes
- Others
- China Radiopharmaceuticals Market, by Type
- Japan
- Japan Radiopharmaceuticals Market, by Type
- Diagnostic Nuclear Medicine
- SPECT Radiopharmaceuticals
- Technetium-99m
- Thallium-201
- Gallium-67
- Iodine-123
- Other
- PET Radiopharmaceuticals
- F-18
- RU-82
- Others
- Therapeutic Nuclear Medicine
- Alpha Emitters
- Ra-223
- Brachytherapy Isotopes
- Intoiodine-125
- Palladium-103
- Cesium-131
- Iridium-192
- Other brachytherapy isotopes
- Beta Emitters
- Intoiodine-131
- Yttrium-90
- Samarium-153
- Lutetium-177
- Rhenium-186
- Other beta emitters
- Japan Radiopharmaceuticals Market, by Application
- Diagnostic Applications
- SPECT Applications
- Cardiology
- Bone Scans
- Thyroid Applications
- Pulmonary Scans
- Other SPECT Applications
- PET applications
- Oncology
- Cardiology
- Neurology
- Other PET applications
- Therapeutic Applications
- Thyroid Indications
- Bone Metastasis
- Lymphoma
- Endocrine Tumors
- Other Indications
- Japan Radiopharmaceuticals Market, by Procedural Volume Assessment
- Diagnostic Procedures
- Therapeutic Procedures
- Source
- Japan Radiopharmaceuticals Market, by Source
- Nuclear Reactors
- Cyclotrons
- Japan Radiopharmaceuticals Market, by End User
- Hospitals
- Ambulatory Surgical Centers
- Diagnostic Centers
- Cancer Research Institutes
- Others
- Japan Radiopharmaceuticals Market, by Type
-
Germany
- Germany Radiopharmaceuticals Market, by Type
- Diagnostic Nuclear Medicine
- SPECT Radiopharmaceuticals
- Technetium-99m
- Thallium-201
- Gallium-67
- Iodine-123
- Other
- PET Radiopharmaceuticals
- F-18
- RU-82
- Others
- Therapeutic Nuclear Medicine
- Alpha Emitters
- Ra-223
- Brachytherapy Isotopes
- Intoiodine-125
- Palladium-103
- Cesium-131
- Iridium-192
- Other brachytherapy isotopes
- Beta Emitters
- Intoiodine-131
- Yttrium-90
- Samarium-153
- Lutetium-177
- Rhenium-186
- Other beta emitters
- Germany Radiopharmaceuticals Market, by Application
- Diagnostic Applications
- SPECT Applications
- Cardiology
- Bone Scans
- Thyroid Applications
- Pulmonary Scans
- Other SPECT Applications
- PET applications
- Oncology
- Cardiology
- Neurology
- Other PET applications
- Therapeutic Applications
- Thyroid Indications
- Bone Metastasis
- Lymphoma
- Endocrine Tumors
- Other Indications
- Germany Radiopharmaceuticals Market, by Procedural Volume Assessment
- Diagnostic Procedures
- Therapeutic Procedures
- Source
- Germany Radiopharmaceuticals Market, by Source
- Nuclear Reactors
- Cyclotrons
- Germany Radiopharmaceuticals Market, by End User
- Hospitals
- Ambulatory Surgical Centers
- Diagnostic Centers
- Cancer Research Institutes
- Others
- Germany Radiopharmaceuticals Market, by Type
-
India
- India Radiopharmaceuticals Market, by Type
- Diagnostic Nuclear Medicine
- SPECT Radiopharmaceuticals
- Technetium-99m
- Thallium-201
- Gallium-67
- Iodine-123
- Other
- PET Radiopharmaceuticals
- F-18
- RU-82
- Others
- Therapeutic Nuclear Medicine
- Alpha Emitters
- Ra-223
- Brachytherapy Isotopes
- Intoiodine-125
- Palladium-103
- Cesium-131
- Iridium-192
- Other brachytherapy isotopes
- Beta Emitters
- Intoiodine-131
- Yttrium-90
- Samarium-153
- Lutetium-177
- Rhenium-186
- Other beta emitters
- India Radiopharmaceuticals Market, by Application
- Diagnostic Applications
- SPECT Applications
- Cardiology
- Bone Scans
- Thyroid Applications
- Pulmonary Scans
- Other SPECT Applications
- PET applications
- Oncology
- Cardiology
- Neurology
- Other PET applications
- Therapeutic Applications
- Thyroid Indications
- Bone Metastasis
- Lymphoma
- Endocrine Tumors
- Other Indications
- India Radiopharmaceuticals Market, by Procedural Volume Assessment
- Diagnostic Procedures
- Therapeutic Procedures
- Source
- India Radiopharmaceuticals Market, by Source
- Nuclear Reactors
- Cyclotrons
- India Radiopharmaceuticals Market, by End User
- Hospitals
- Ambulatory Surgical Centers
- Diagnostic Centers
- Cancer Research Institutes
- Others
- India Radiopharmaceuticals Market, by Type
-
South Korea
- South Korea Radiopharmaceuticals Market, by Type
- Diagnostic Nuclear Medicine
- SPECT Radiopharmaceuticals
- Technetium-99m
- Thallium-201
- Gallium-67
- Iodine-123
- Other
- PET Radiopharmaceuticals
- F-18
- RU-82
- Others
- Therapeutic Nuclear Medicine
- Alpha Emitters
- Ra-223
- Brachytherapy Isotopes
- Intoiodine-125
- Palladium-103
- Cesium-131
- Iridium-192
- Other brachytherapy isotopes
- Beta Emitters
- Intoiodine-131
- Yttrium-90
- Samarium-153
- Lutetium-177
- Rhenium-186
- Other beta emitters
- South Korea Radiopharmaceuticals Market, by Application
- Diagnostic Applications
- SPECT Applications
- Cardiology
- Bone Scans
- Thyroid Applications
- Pulmonary Scans
- Other SPECT Applications
- PET applications
- Oncology
- Cardiology
- Neurology
- Other PET applications
- Therapeutic Applications
- Thyroid Indications
- Bone Metastasis
- Lymphoma
- Endocrine Tumors
- Other Indications
- South Korea Radiopharmaceuticals Market, by Procedural Volume Assessment
- Diagnostic Procedures
- Therapeutic Procedures
- Source
- South Korea Radiopharmaceuticals Market, by Source
- Nuclear Reactors
- Cyclotrons
- South Korea Radiopharmaceuticals Market, by End User
- Hospitals
- Ambulatory Surgical Centers
- Diagnostic Centers
- Cancer Research Institutes
- Others
- South Korea Radiopharmaceuticals Market, by Type
-
South East Asia
- South East Asia Radiopharmaceuticals Market, by Type
- Diagnostic Nuclear Medicine
- SPECT Radiopharmaceuticals
- Technetium-99m
- Thallium-201
- Gallium-67
- Iodine-123
- Other
- PET Radiopharmaceuticals
- F-18
- RU-82
- Others
- Therapeutic Nuclear Medicine
- Alpha Emitters
- Ra-223
- Brachytherapy Isotopes
- Intoiodine-125
- Palladium-103
- Cesium-131
- Iridium-192
- Other brachytherapy isotopes
- Beta Emitters
- Intoiodine-131
- Yttrium-90
- Samarium-153
- Lutetium-177
- Rhenium-186
- Other beta emitters
- South East Asia Radiopharmaceuticals Market, by Application
- Diagnostic Applications
- SPECT Applications
- Cardiology
- Bone Scans
- Thyroid Applications
- Pulmonary Scans
- Other SPECT Applications
- PET applications
- Oncology
- Cardiology
- Neurology
- Other PET applications
- Therapeutic Applications
- Thyroid Indications
- Bone Metastasis
- Lymphoma
- Endocrine Tumors
- Other Indications
- South East Asia Radiopharmaceuticals Market, by Procedural Volume Assessment
- Diagnostic Procedures
- Therapeutic Procedures
- Source
- South East Asia Radiopharmaceuticals Market, by Source
- Nuclear Reactors
- Cyclotrons
- South East Asia Radiopharmaceuticals Market, by End User
- Hospitals
- Ambulatory Surgical Centers
- Diagnostic Centers
- Cancer Research Institutes
- Others
- South East Asia Radiopharmaceuticals Market, by Type
-
Rest of Asia Pacific
- Rest of Asia Pacific Radiopharmaceuticals Market, by Type
- Diagnostic Nuclear Medicine
- SPECT Radiopharmaceuticals
- Technetium-99m
- Thallium-201
- Gallium-67
- Iodine-123
- Other
- PET Radiopharmaceuticals
- F-18
- RU-82
- Others
- Therapeutic Nuclear Medicine
- Alpha Emitters
- Ra-223
- Brachytherapy Isotopes
- Intoiodine-125
- Palladium-103
- Cesium-131
- Iridium-192
- Other brachytherapy isotopes
- Beta Emitters
- Intoiodine-131
- Yttrium-90
- Samarium-153
- Lutetium-177
- Rhenium-186
- Other beta emitters
- Rest of Asia Pacific Radiopharmaceuticals Market, by Application
- Diagnostic Applications
- SPECT Applications
- Cardiology
- Bone Scans
- Thyroid Applications
- Pulmonary Scans
- Other SPECT Applications
- PET applications
- Oncology
- Cardiology
- Neurology
- Other PET applications
- Therapeutic Applications
- Thyroid Indications
- Bone Metastasis
- Lymphoma
- Endocrine Tumors
- Other Indications
- Rest of Asia Pacific Radiopharmaceuticals Market, by Procedural Volume Assessment
- Diagnostic Procedures
- Therapeutic Procedures
- Source
- Rest of Asia Pacific Radiopharmaceuticals Market, by Source
- Nuclear Reactors
- Cyclotrons
- Rest of Asia Pacific Radiopharmaceuticals Market, by End User
- Hospitals
- Ambulatory Surgical Centers
- Diagnostic Centers
- Cancer Research Institutes
- Others
- Rest of Asia Pacific Radiopharmaceuticals Market, by Type
-
Asia Pacific Radiopharmaceuticals Market, by Type
- Latin America
-
Latin America Radiopharmaceuticals Market, by Type
- Diagnostic Nuclear Medicine
- SPECT Radiopharmaceuticals
- Technetium-99m
- Thallium-201
- Gallium-67
- Iodine-123
- Other
- PET Radiopharmaceuticals
- F-18
- RU-82
- Others
- Therapeutic Nuclear Medicine
- Alpha Emitters
- Ra-223
- Brachytherapy Isotopes
- Intoiodine-125
- Palladium-103
- Cesium-131
- Iridium-192
- Other brachytherapy isotopes
- Beta Emitters
- Intoiodine-131
- Yttrium-90
- Samarium-153
- Lutetium-177
- Rhenium-186
- Other beta emitters
-
Latin America Radiopharmaceuticals Market, by Application
- Diagnostic Applications
- SPECT Applications
- Cardiology
- Bone Scans
- Thyroid Applications
- Pulmonary Scans
- Other SPECT Applications
- PET applications
- Oncology
- Cardiology
- Neurology
- Other PET applications
- Therapeutic Applications
- Thyroid Indications
- Bone Metastasis
- Lymphoma
- Endocrine Tumors
- Other Indications
-
Latin America Radiopharmaceuticals Market, by Procedural Volume Assessment
- Diagnostic Procedures
- Therapeutic Procedures
- Source
-
Latin America Radiopharmaceuticals Market, by Source
- Nuclear Reactors
- Cyclotrons
-
Latin America Radiopharmaceuticals Market, by End User
- Hospitals
- Ambulatory Surgical Centers
- Diagnostic Centers
- Cancer Research Institutes
- Others
- Brazil
- Brazil Radiopharmaceuticals Market, by Type
- Diagnostic Nuclear Medicine
- SPECT Radiopharmaceuticals
- Technetium-99m
- Thallium-201
- Gallium-67
- Iodine-123
- Other
- PET Radiopharmaceuticals
- F-18
- RU-82
- Others
- Therapeutic Nuclear Medicine
- Alpha Emitters
- Ra-223
- Brachytherapy Isotopes
- Intoiodine-125
- Palladium-103
- Cesium-131
- Iridium-192
- Other brachytherapy isotopes
- Beta Emitters
- Intoiodine-131
- Yttrium-90
- Samarium-153
- Lutetium-177
- Rhenium-186
- Other beta emitters
- Brazil Radiopharmaceuticals Market, by Application
- Diagnostic Applications
- SPECT Applications
- Cardiology
- Bone Scans
- Thyroid Applications
- Pulmonary Scans
- Other SPECT Applications
- PET applications
- Oncology
- Cardiology
- Neurology
- Other PET applications
- Therapeutic Applications
- Thyroid Indications
- Bone Metastasis
- Lymphoma
- Endocrine Tumors
- Other Indications
- Brazil Radiopharmaceuticals Market, by Procedural Volume Assessment
- Diagnostic Procedures
- Therapeutic Procedures
- Source
- Brazil Radiopharmaceuticals Market, by Source
- Nuclear Reactors
- Cyclotrons
- Brazil Radiopharmaceuticals Market, by End User
- Hospitals
- Ambulatory Surgical Centers
- Diagnostic Centers
- Cancer Research Institutes
- Others
- Brazil Radiopharmaceuticals Market, by Type
- Argentina
- Argentina Radiopharmaceuticals Market, by Type
- Diagnostic Nuclear Medicine
- SPECT Radiopharmaceuticals
- Technetium-99m
- Thallium-201
- Gallium-67
- Iodine-123
- Other
- PET Radiopharmaceuticals
- F-18
- RU-82
- Others
- Therapeutic Nuclear Medicine
- Alpha Emitters
- Ra-223
- Brachytherapy Isotopes
- Intoiodine-125
- Palladium-103
- Cesium-131
- Iridium-192
- Other brachytherapy isotopes
- Beta Emitters
- Intoiodine-131
- Yttrium-90
- Samarium-153
- Lutetium-177
- Rhenium-186
- Other beta emitters
- Argentina Radiopharmaceuticals Market, by Application
- Diagnostic Applications
- SPECT Applications
- Cardiology
- Bone Scans
- Thyroid Applications
- Pulmonary Scans
- Other SPECT Applications
- PET applications
- Oncology
- Cardiology
- Neurology
- Other PET applications
- Therapeutic Applications
- Thyroid Indications
- Bone Metastasis
- Lymphoma
- Endocrine Tumors
- Other Indications
- Argentina Radiopharmaceuticals Market, by Procedural Volume Assessment
- Diagnostic Procedures
- Therapeutic Procedures
- Source
- Argentina Radiopharmaceuticals Market, by Source
- Nuclear Reactors
- Cyclotrons
- Argentina Radiopharmaceuticals Market, by End User
- Hospitals
- Ambulatory Surgical Centers
- Diagnostic Centers
- Cancer Research Institutes
- Others
- Argentina Radiopharmaceuticals Market, by Type
-
Rest of Latin America
- Rest of Latin America Radiopharmaceuticals Market, by Type
- Diagnostic Nuclear Medicine
- SPECT Radiopharmaceuticals
- Technetium-99m
- Thallium-201
- Gallium-67
- Iodine-123
- Other
- PET Radiopharmaceuticals
- F-18
- RU-82
- Others
- Therapeutic Nuclear Medicine
- Alpha Emitters
- Ra-223
- Brachytherapy Isotopes
- Intoiodine-125
- Palladium-103
- Cesium-131
- Iridium-192
- Other brachytherapy isotopes
- Beta Emitters
- Intoiodine-131
- Yttrium-90
- Samarium-153
- Lutetium-177
- Rhenium-186
- Other beta emitters
- Rest of Latin America Radiopharmaceuticals Market, by Application
- Diagnostic Applications
- SPECT Applications
- Cardiology
- Bone Scans
- Thyroid Applications
- Pulmonary Scans
- Other SPECT Applications
- PET applications
- Oncology
- Cardiology
- Neurology
- Other PET applications
- Therapeutic Applications
- Thyroid Indications
- Bone Metastasis
- Lymphoma
- Endocrine Tumors
- Other Indications
- Rest of Latin America Radiopharmaceuticals Market, by Procedural Volume Assessment
- Diagnostic Procedures
- Therapeutic Procedures
- Source
- Rest of Latin America Radiopharmaceuticals Market, by Source
- Nuclear Reactors
- Cyclotrons
- Rest of Latin America Radiopharmaceuticals Market, by End User
- Hospitals
- Ambulatory Surgical Centers
- Diagnostic Centers
- Cancer Research Institutes
- Others
- Rest of Latin America Radiopharmaceuticals Market, by Type
-
Latin America Radiopharmaceuticals Market, by Type
- Middle East & Africa
-
Middle East & Africa Radiopharmaceuticals Market, by Type
- Diagnostic Nuclear Medicine
- SPECT Radiopharmaceuticals
- Technetium-99m
- Thallium-201
- Gallium-67
- Iodine-123
- Other
- PET Radiopharmaceuticals
- F-18
- RU-82
- Others
- Therapeutic Nuclear Medicine
- Alpha Emitters
- Ra-223
- Brachytherapy Isotopes
- Intoiodine-125
- Palladium-103
- Cesium-131
- Iridium-192
- Other brachytherapy isotopes
- Beta Emitters
- Intoiodine-131
- Yttrium-90
- Samarium-153
- Lutetium-177
- Rhenium-186
- Other beta emitters
-
Middle East & Africa Radiopharmaceuticals Market, by Application
- Diagnostic Applications
- SPECT Applications
- Cardiology
- Bone Scans
- Thyroid Applications
- Pulmonary Scans
- Other SPECT Applications
- PET applications
- Oncology
- Cardiology
- Neurology
- Other PET applications
- Therapeutic Applications
- Thyroid Indications
- Bone Metastasis
- Lymphoma
- Endocrine Tumors
- Other Indications
-
Middle East & Africa Radiopharmaceuticals Market, by Procedural Volume Assessment
- Diagnostic Procedures
- Therapeutic Procedures
- Source
-
Middle East & Africa Radiopharmaceuticals Market, by Source
- Nuclear Reactors
- Cyclotrons
-
Middle East & Africa Radiopharmaceuticals Market, by End User
- Hospitals
- Ambulatory Surgical Centers
- Diagnostic Centers
- Cancer Research Institutes
- Others
- GCC Countries
- GCC Countries Radiopharmaceuticals Market, by Type
- Diagnostic Nuclear Medicine
- SPECT Radiopharmaceuticals
- Technetium-99m
- Thallium-201
- Gallium-67
- Iodine-123
- Other
- PET Radiopharmaceuticals
- F-18
- RU-82
- Others
- Therapeutic Nuclear Medicine
- Alpha Emitters
- Ra-223
- Brachytherapy Isotopes
- Intoiodine-125
- Palladium-103
- Cesium-131
- Iridium-192
- Other brachytherapy isotopes
- Beta Emitters
- Intoiodine-131
- Yttrium-90
- Samarium-153
- Lutetium-177
- Rhenium-186
- Other beta emitters
- GCC Countries Radiopharmaceuticals Market, by Application
- Diagnostic Applications
- SPECT Applications
- Cardiology
- Bone Scans
- Thyroid Applications
- Pulmonary Scans
- Other SPECT Applications
- PET applications
- Oncology
- Cardiology
- Neurology
- Other PET applications
- Therapeutic Applications
- Thyroid Indications
- Bone Metastasis
- Lymphoma
- Endocrine Tumors
- Other Indications
- GCC Countries Radiopharmaceuticals Market, by Procedural Volume Assessment
- Diagnostic Procedures
- Therapeutic Procedures
- Source
- GCC Countries Radiopharmaceuticals Market, by Source
- Nuclear Reactors
- Cyclotrons
- GCC Countries Radiopharmaceuticals Market, by End User
- Hospitals
- Ambulatory Surgical Centers
- Diagnostic Centers
- Cancer Research Institutes
- Others
- GCC Countries Radiopharmaceuticals Market, by Type
- South Africa
- South Africa Radiopharmaceuticals Market, by Type
- Diagnostic Nuclear Medicine
- SPECT Radiopharmaceuticals
- Technetium-99m
- Thallium-201
- Gallium-67
- Iodine-123
- Other
- PET Radiopharmaceuticals
- F-18
- RU-82
- Others
- Therapeutic Nuclear Medicine
- Alpha Emitters
- Ra-223
- Brachytherapy Isotopes
- Intoiodine-125
- Palladium-103
- Cesium-131
- Iridium-192
- Other brachytherapy isotopes
- Beta Emitters
- Intoiodine-131
- Yttrium-90
- Samarium-153
- Lutetium-177
- Rhenium-186
- Other beta emitters
- South Africa Radiopharmaceuticals Market, by Application
- Diagnostic Applications
- SPECT Applications
- Cardiology
- Bone Scans
- Thyroid Applications
- Pulmonary Scans
- Other SPECT Applications
- PET applications
- Oncology
- Cardiology
- Neurology
- Other PET applications
- Therapeutic Applications
- Thyroid Indications
- Bone Metastasis
- Lymphoma
- Endocrine Tumors
- Other Indications
- South Africa Radiopharmaceuticals Market, by Procedural Volume Assessment
- Diagnostic Procedures
- Therapeutic Procedures
- Source
- South Africa Radiopharmaceuticals Market, by Source
- Nuclear Reactors
- Cyclotrons
- South Africa Radiopharmaceuticals Market, by End User
- Hospitals
- Ambulatory Surgical Centers
- Diagnostic Centers
- Cancer Research Institutes
- Others
- South Africa Radiopharmaceuticals Market, by Type
-
Rest of Middle East & Africa
- Rest of Middle East & Africa Radiopharmaceuticals Market, by Type
- Diagnostic Nuclear Medicine
- SPECT Radiopharmaceuticals
- Technetium-99m
- Thallium-201
- Gallium-67
- Iodine-123
- Other
- PET Radiopharmaceuticals
- F-18
- RU-82
- Others
- Therapeutic Nuclear Medicine
- Alpha Emitters
- Ra-223
- Brachytherapy Isotopes
- Intoiodine-125
- Palladium-103
- Cesium-131
- Iridium-192
- Other brachytherapy isotopes
- Beta Emitters
- Intoiodine-131
- Yttrium-90
- Samarium-153
- Lutetium-177
- Rhenium-186
- Other beta emitters
- Rest of Middle East & Africa Radiopharmaceuticals Market, by Application
- Diagnostic Applications
- SPECT Applications
- Cardiology
- Bone Scans
- Thyroid Applications
- Pulmonary Scans
- Other SPECT Applications
- PET applications
- Oncology
- Cardiology
- Neurology
- Other PET applications
- Therapeutic Applications
- Thyroid Indications
- Bone Metastasis
- Lymphoma
- Endocrine Tumors
- Other Indications
- Rest of Middle East & Africa Radiopharmaceuticals Market, by Procedural Volume Assessment
- Diagnostic Procedures
- Therapeutic Procedures
- Source
- Rest of Middle East & Africa Radiopharmaceuticals Market, by Source
- Nuclear Reactors
- Cyclotrons
- Rest of Middle East & Africa Radiopharmaceuticals Market, by End User
- Hospitals
- Ambulatory Surgical Centers
- Diagnostic Centers
- Cancer Research Institutes
- Others
- Rest of Middle East & Africa Radiopharmaceuticals Market, by Type
-
Middle East & Africa Radiopharmaceuticals Market, by Type
- North America
Vantage Market
Research | 24-May-2023
FAQ
Frequently Asked Question
What is the global demand for Radiopharmaceuticals in terms of revenue?
-
The global Radiopharmaceuticals valued at USD 5.2 Billion in 2022 and is expected to reach USD 9.75 Billion in 2030 growing at a CAGR of 9.4%.
Which are the prominent players in the market?
-
The prominent players in the market are Cardinal Health (U.S.), GE Healthcare (U.S.), Lantheus Medical Imaging (U.S.), Bayer AG (Germany), Bracco Imaging (Italy), Nordion (Canada), Advanced Accelerator Applications (France), NTP Radioisotopes (South Africa), NorthStar Medical Radioisotopes (U.S.), Eckert & Ziegler (Germany), Braun Melsungen AG (Germany), Smith+Nephew (Germany), Zimmer Biomet (U.S.), Hanger Inc. (U.S.) and Otto Bock Healthcare GmBH (Germany).
At what CAGR is the market projected to grow within the forecast period?
-
The market is project to grow at a CAGR of 9.4% between 2023 and 2030.
What are the driving factors fueling the growth of the market.
-
The driving factors of the Radiopharmaceuticals include
- Increasing Cases of Cancer and Heart Diseases
Which region accounted for the largest share in the market?
-
North America was the leading regional segment of the Radiopharmaceuticals in 2022.
